Northwestern Mutual Wealth Management
MRKR icon

Northwestern Mutual Wealth Management’s Marker Therapeutics MRKR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9
Closed -$49 – 3759
2024
Q2 		$49 Buy
+9
New +$38 ﹤0.01% 3423

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return

Northwestern Mutual Wealth Management's MRKR Position: Q3 2024 in Review

Northwestern Mutual Wealth Management sold out of Marker Therapeutics (MRKR) in Q3 2024, closing a stake of 9 shares — an estimated $49 sold.

Northwestern Mutual Wealth Management first reported a position in MRKR in Q2 2024 and held it in 1 quarter. The position peaked at $49 in Q2 2024. 28 funds tracked by Wall St. Rank hold MRKR as of Q3 2024.

  • Northwestern Mutual Wealth Management reported no remaining Marker Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 9 Marker Therapeutics shares in Q3 2024, an estimated $49.
  • Northwestern Mutual Wealth Management first reported a position in Marker Therapeutics in Q2 2024 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Marker Therapeutics position peaked at $49 in Q2 2024.
  • 28 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.